Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast CancerGuillermo Villacampa, Tomás Pascual, Francesco Schettini et al.|JAMA Oncology|2024Cited by 77
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysisAdela Escudero, Guillermo Villacampa, Meritxell Bellet et al.|Cancer Treatment Reviews|2025Cited by 3